))
Revolutionizing ALS Drug Development with Dr. Kasper Roet
Manage episode 473243596 series 3557210
Content provided by Karen Toffler Charitable Trust. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Karen Toffler Charitable Trust or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
Welcome to Research Renaissance, presented by the Karen Toffler Charitable Trust. In this episode, host Deborah Westphal sits down with Dr. Kasper Roet, CEO and co-founder of QurAlis, to explore the evolution of ALS drug development, the power of genetic insights, and the future of personalized medicine for neurodegenerative diseases.
🔬 Episode Highlights:
✔️ From Spinal Cord Injury to ALS – Dr. Roet’s journey from spinal cord injury research to ALS, and how genetic discoveries reshaped his focus.
✔️ A New Era for Drug Development – The pivotal role of genomics, AI, and stem cell technology in accelerating ALS treatments.
✔️ Precision Medicine & Stem Cells – How patient-derived pluripotent stem cells are transforming ALS research.
✔️ Cure ALS: The Mission & Breakthroughs – The pioneering therapies Quralis is developing to target ALS at the molecular level.
✔️ Challenges in Biotech Entrepreneurship – The leap from scientist to CEO, raising funds, and the mentorship that helped shape his journey.
✔️ The Future of Neurological Disease Research – What’s next for genetic medicine, biomarkers, and targeted treatments?
💡 Key Takeaways:
🔹 ALS is no longer a “mystery disease” – recent genetic breakthroughs are leading to targeted treatments.
🔹 Traditional animal models are failing to replicate human disease—patient-derived stem cells are offering a more reliable solution.
🔹 The intersection of AI, big data, and molecular biology will drive the next wave of personalized medicine.
🔹 Biotech innovation demands a balance between scientific rigor and entrepreneurial agility.
🔹 The industry must shorten drug development timelines to bring life-saving treatments to patients faster.
🎧 Listen Now & Subscribe!
Stay ahead in the world of cutting-edge neuroscience and biotech breakthroughs. Subscribe to Research Renaissance on your favorite podcast platform and visit TofflerTrust.org for more insights.
🔗 Want to collaborate or learn more? Connect with Dr. Kasper Roet and his team at Quralis or email [email protected].
🚀 Join us in advancing the future of brain research—because patients can’t wait!
To learn more about the breakthroughs discussed in this episode and to support ongoing research, visit our website at tofflertrust.org.
Technical Podcast Support by Jon Keur at Wayfare Recording Co.
44 episodes
Share
